Redhill Biopharma Ltd. - American Depositary Shares (RDHL)
0.9786
+0.0786 (8.73%)
NASDAQ· Last Trade: Sep 1st, 8:02 AM EDT
Detailed Quote
Previous Close
0.9000
Open
-
Bid
0.8356
Ask
0.8364
Day's Range
N/A - N/A
52 Week Range
0.5700 - 2.790
Volume
1,371,296
Market Cap
-
PE Ratio (TTM)
-
EPS (TTM)
-
Dividend & Yield
N/A (N/A)
1 Month Average Volume
4,968,241
Chart
About Redhill Biopharma Ltd. - American Depositary Shares (RDHL)
Redhill Biopharma is a biopharmaceutical company focused on the development and commercialization of innovative therapies for gastrointestinal diseases and other serious conditions. The company specializes in creating novel formulations and repurposing existing drugs to improve treatment outcomes for patients. Redhill is dedicated to addressing unmet medical needs through its robust pipeline of products, which includes both clinical-stage candidates and marketed drugs. By leveraging advanced scientific research and a strategic approach to drug development, Redhill aims to improve the lives of patients suffering from complex health issues. Read More
September 01, 2026 Several small-cap stocks are drawing investor attention following new corporate developments spanning biotechnology, military robotics, real estate and AI-enabled travel, with RedHill Biopharma Ltd. (NASDAQ: RDHL), Peraso Inc. (NASDAQ: PRSO), LogProstyle Inc. (NYSE: LGPS) and Webuy Global Ltd. (NASDAQ: WBUY) among the names in focus.
Gainers Redhill Biopharma (NASDAQ:RDHL) stock increased by 69.4% to $1.12 during Monday's regular session. The company's market cap stands at $4.0 million. CollPlant Biotechnologies (NASDAQ:CLGN) shares
Gainers Redhill Biopharma (NASDAQ:RDHL) shares increased by 96.7% to $1.3 during Monday's pre-market session. The market value of their outstanding shares is at $4.0 million. Vivos Therapeutics (NASDAQ:VVOS) stock
Gainers Dogwood Therapeutics (NASDAQ: DWTX) stock moved upwards by 80.1% to $9.94 during Monday's pre-market session. The market value of their outstanding shares is at $10.5 million.
Wondering how the US markets performed one hour before the close of the markets on Monday? Discover the movers and shakers of today's session in our comprehensive analysis.
Let's have a look at what is happening on the US markets after the closing bell on Wednesday. Below you can find the top gainers and losers in today's after hours session.
New Prostate Cancer Hope? Bayer-Funded Phase 2 Study To Test Combination Of RedHill's Opaganib And Bayer’s Darolutamide, To Overcome Androgen Resistance
